Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)

Figure 1

Initiation of the coagulation and angiogenic cascades by pancreatic tumour cells (modified from [61]). Figure legend text: TF, tissue factor; VEGF, vascular endothelial growth factor; PAR, protease-activated receptor; TSP, thrombospondin; HGBF2, heparin-binding growth factor 2 (previously called fibroblast growth factor 2 [FGF-2]).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us